Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guérin Instillations for Bladder Cancer - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Clinical Genitourinary Cancer Year : 2015

Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guérin Instillations for Bladder Cancer

Abstract

We describe a local reaction to intravesical bacillus Calmette-Guérin (BCG) instillations for the treatment of bladder cancer, with different profiles of urinary cytokine production during treatment. This analysis reflects a specific immune response induced in each patient. Their assessment could allow a more reliable selection of the patients eligible for this type of treatment and could help justify maintenance BCG therapy. Background: We sought to demonstrate a correlation between the response to treatment and the profile of urinary cytokine production during bacillus Calmette-Guérin (BCG) therapy. Material and Methods: From December 2008 to February 2011, 23 patients were included in a prospective study. All patients received 6 instillations of BCG weekly. The mean follow-up period of the population was 16.9 AE 8.4 months. Refractory disease or recurrence was observed in 5 patients. Urine samples were collected and stored at À80 C, before and 4 hours after the first, third, and sixth BCG instillations. The cytokines (interleukin [IL]-2, IL-4, IL-6, IL-10, IL-17, interferon-gamma [IFNg] and tumor necrosis factor-alpha) were quantified within the collected urine samples using cytometric bead array analysis. The quantitative variables were analyzed using Student's t test, and regression statistical analysis was performed. Results: Urinary cytokine production had increased strongly 4 hours after the sixth instillation but only mildly to moderately after the first and third instillations. IL-2 and IL-6 showed the most dramatic changes after the BCG instillations. Different urinary cytokine production profiles were demonstrated. A trend was observed for the BCG-refractory/recurrence group, with high baseline IL-6 levels, followed by low IL-6 levels before the instillations; low baseline IL-2 levels with only minor changes during treatment; the absence of IFNg and IL-17 production; and a low peak of cytokine production at the end of treatment. Conclusion: Analysis of the urinary cytokine production levels during BCG therapy reflect a specific immune response induced in each patient. Their assessment could allow a more reliable selection of patients eligible for this type of treatment and could help justify the use of maintenance BCG therapy.

Domains

Cancer
Embargoed file
Embargoed file
Visibility date is undetermined
Loading...

Dates and versions

inserm-01280788 , version 1 (01-03-2016)

Identifiers

Cite

Jérôme Rigaud, Alexandra Leger, Marie-Claire Devilder, Olivier Bouchot, Marc Bonneville, et al.. Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guérin Instillations for Bladder Cancer. Clinical Genitourinary Cancer, 2015, pp.e209. ⟨10.1016/j.clgc.2015.01.005⟩. ⟨inserm-01280788⟩
219 View
2 Download

Altmetric

Share

Gmail Facebook X LinkedIn More